Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Return on Assets (2022 - 2025)

Historic Return on Assets for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to 0.7%.

  • Atara Biotherapeutics' Return on Assets rose 17200.0% to 0.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.7%, marking a year-over-year increase of 17200.0%. This contributed to the annual value of 0.62% for FY2024, which is 4000.0% up from last year.
  • According to the latest figures from Q3 2025, Atara Biotherapeutics' Return on Assets is 0.7%, which was up 17200.0% from 0.12% recorded in Q2 2025.
  • Atara Biotherapeutics' Return on Assets' 5-year high stood at 0.7% during Q3 2025, with a 5-year trough of 1.56% in Q4 2023.
  • Its 4-year average for Return on Assets is 0.75%, with a median of 0.85% in 2024.
  • Per our database at Business Quant, Atara Biotherapeutics' Return on Assets plummeted by -9500bps in 2023 and then surged by 17200bps in 2025.
  • Quarter analysis of 4 years shows Atara Biotherapeutics' Return on Assets stood at 0.61% in 2022, then plummeted by -154bps to 1.56% in 2023, then surged by 57bps to 0.68% in 2024, then soared by 203bps to 0.7% in 2025.
  • Its Return on Assets stands at 0.7% for Q3 2025, versus 0.12% for Q2 2025 and 0.18% for Q1 2025.